Abstract

Glucosamine is a natural substance that has been widely used for several years as a food supplement to treat people with osteoarthritis.1 One formulation of ▼glucosamine hydrochloride (Alateris – Ransom) has recently become the first (and is currently the only) glucosamine product to be licensed as a medicine in the UK for symptomatic relief of mild to moderate osteoarthritis of the knee. In 2002, we concluded that unlicensed “oral glucosamine sulphate 1,500 mg [daily] probably provides modest symptom relief in patients with osteoarthritis of the knee and its efficacy appears similar to that of NSAIDs”.1 Here we update our advice in the light of new evidence and assess the place of the licensed glucosamine hydrochloride tablets.